The acetylation state of histones is modulated by histone deacetylase (HDAC) and histone acetyltransferase and is an important component in regulating gene transcription, including neuronal differentiation. The authors studied the relationship between histone acetylation and the differentiation and survival of the RGC-5 cell line and compared it with nontranscriptional-dependent differentiation with staurosporine. METHODS. The retinal ganglion cell line RGC-5 was treated with trichostatin A (TSA), other HDAC inhibitors, and staurosporine; differentiation, neuritogenesis, neurotrophic factor dependence, and dependence on RNA transcription were assessed. RESULTS. TSA caused significant differentiation and neuritogenesis. Differences between HDAC inhibition and staurosporine differentiation included the proportion of differentiated cells, cell viability, cell morphology, and transcriptional dependence. HDAC inhibition, but not staurosporine differentiation, resulted in RGC-5 cells that were neurotrophic factor dependent. CONCLUSIONS. These results implicate two different mechanisms for RGC-5 differentiation, with a common downstream effect on neurite outgrowth but a differential effect on neurotrophic factor dependence. (Invest Ophthalmol Vis Sci.
T he differentiation of progenitor cells is an important step in the repopulation of neurons from stem cells. Progenitor cells may be differentiated in vivo after transplantation or differentiated in vitro before transplantation. 1 In both cases, the eventual functional replacement of the absent neuronal population requires appropriate differentiation signals. We used as a model system the retinal ganglion cell line RGC-5, which was immortalized from a committed RGC progenitor cell at postnatal day (P)1. 2 We have previously shown that the nonspecific kinase inhibitor staurosporine can induce the mitotically active RGC-5 cell line to stop proliferation, extend neurites, and express many of the electrophysiological and histochemical markers characteristic of primary RGCs. 3 However, staurosporine-differentiated RGC-5 cells differ in significant ways from primary cultured RGCs. Staurosporine differentiation is transcription independent and results in cells that are viable in the absence of any neurotrophic factor support, unlike normally differentiated RGCs. Neurotrophic factor dependence would be a necessary component of reproducing functional connectivity of neurons to central nervous system targets, 4 which is the goal of in vivo application of neuronal stem cells.
Here we report that histone deacetylase (HDAC) inhibition differentiates RGC-5 cells in a manner that is transcription dependent and that results in neurotrophic factor-dependent cells. We focused on trichostatin A (TSA), a potent, specific, and well-characterized class 1 and class 2 HDAC inhibitor 5, 6 reported to induce differentiation in rat hippocampal neural progenitor cells and Neuro 2a cells. 7, 8 We found that TSA induces neurite outgrowth from RGC-5 cells that are morphologically, quantitatively, and mechanistically different from the differentiation induced by staurosporine, suggesting that HDAC inhibition holds promise as a method for differentiating RGC progenitors in vitro.
MATERIALS AND METHODS

Materials
TSA was purchased from A.G. Scientific (San Diego, CA); ␣-amanitin from AXXORA (San Diego, CA); brain-derived neurotrophic factor (BDNF) and ciliary neurotrophic factor (CNTF) from PeproTech (Rocky Hill, NJ); insulin, forskolin, bromodeoxyuridine (BrdU), monoclonal mouse anti-BrdU (clone Bu 33), rabbit anti-actin, and dimethyl sulfoxide (DMSO) from Sigma-Aldrich (St. Louis, MO); staurosporine (from Streptomyces staurosporeus; 98% or greater purity; catalog number 380 -014) from Alexis Biochemicals (San Diego, CA); monoclonal mouse anti-tau-1 (catalog number MAB3420), polyclonal rabbit anti-MAP2 (catalog number AB5622), polyclonal rabbit anti-Brn-3a (catalog number AB5945), horseradish peroxidase (HRP)-conjugated donkey anti-goat IgG, and HRP-conjugated goat anti-rabbit IgG antibodies from Chemicon (Temecula, CA); polyclonal goat anti-Brn-3b antibody (catalog number sc-31,987) from Santa Cruz Biotechnology (Santa Cruz, CA); monoclonal mouse anti-H3 (catalog number 05-499) and polyclonal rabbit anti-acetyl-H3 (catalog number 06-599) antibodies from Upstate (Lake Placid, NY); goat anti-mouse IgG and goat anti-rabbit IgG from LI-COR (IRDye 800 and IRDye 680, respectively; Lincoln, NE); and Alexa Fluor 594 goat anti-mouse IgG, Alexa Fluor 488 goat anti-rabbit IgG antibodies, and propidium iodide (PI) from Molecular Probes (Eugene, OR). Cell culture reagents, unless otherwise noted, were from BioWhittaker (Rockland, ME).
Cell Culture
RGC-5 cells were cultured as previously described. 3 For proliferation and immunohistochemical experiments, cells were replated on 12-mm round coverglass in 24-well plates at a density of 80 cells/mm 2 in 500 L media 24 hours before pharmacologic treatment. In experiments in which pharmacologic treatments were withdrawn, the original media were replaced under all conditions to control for conditioned media effects. All conditions were tested in duplicate.
The wells were washed with Tris-buffered saline (TBS; 100 mM Tris [pH 7.6], 0.9% NaCl), incubated with blocking buffer (0.3% Triton X-100, 5% normal goat serum in TBS) for 30 minutes at room temperature, and incubated overnight at 4°C with monoclonal mouse antitau-1 and polyclonal rabbit anti-MAP2 antibodies at 4 g/mL in blocking buffer. After washing, cells were incubated for 1 hour at room temperature with goat anti-mouse IgG (Alexa Fluor 594; Molecular Probes) and goat anti-rabbit IgG (Alexa Fluor 488; Molecular Probes) at 2 g/mL in TBS. Coverslips were then transferred and mounted on microscope slides. The resultant tau fluorescence was detected with a Texas Red filter set (excitation 560 Ϯ 20 nm, dichroic 595-nm longpass, emission 630 Ϯ 30 nm), and MAP2 fluorescence was detected with an FITC filter set (excitation 470 Ϯ 20 nm, dichroic 505 nm long-pass, emission 540 Ϯ 20 nm). Digital photomicrographs were taken at 400ϫ total magnification.
Cell Viability
RGC-5 cells were assayed for cell death with PI and visualized by incubation with 2 M PI for 30 minutes at 37°C. To exclude the possibility of removing nonadherent dead cells, media were not aspirated until after imaging. PI fluorescence was detected with a Texas Red filter set, with digital photomicrographs taken at a final magnification of 200ϫ. Dead cells were identified by superimposition of PI fluorescence and phase images of the same fields.
Cell Proliferation
RGC-5 cells were assayed for mitotic activity by staining for BrdU incorporation, as previously described. 3 Proliferating cells were identified by superimposition of BrdU fluorescence and phase images of the same fields.
Quantitative Morphology Assessment
Digital photomicrographs were taken at 200ϫ total magnification various times after pharmacologic treatment. Six photomicrographs were taken, three from each duplicated condition, from different locations around the center of each well. Photomicrographs were batch analyzed offline to assess the development of neurites. The proportion of
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Control + B/C/I/F TSA TSA + B/C/I/F Staurosporine Staurosporine + B/C/I/F FIGURE 1. HDAC inhibition differentiates RGC-5 cells. RGC-5 cells were treated with 500 nM TSA or 316 nM staurosporine, with or without the RGC survival-promoting combination 10 of BDNF (50 ng/mL), CNTF (10 ng/mL), insulin (5 g/mL), and forskolin (5 M; B/C/I/F). Photomicrographs were taken at 200ϫ magnification 24 hours after treatment. Staurosporine and TSA induced neurite outgrowth greater than untreated (control) or B/C/I/F-treated cells. Cells with three or more neurites longer than the soma were classified as differentiated. B/C/I/F alone did not induce differentiation. Scale bar, 50 m. 
Immunoblot Analysis
Relative HDAC inhibition activity of staurosporine was assayed by immunoblotting for total H3 and acetylated H3 in control, TSA-, and staurosporine-treated RGC-5 cells. Cells were plated at a density of 80 cells/mm 2 in 100-mm tissue culture plates and were harvested 24 hours after pharmacologic treatment. Lysates were collected, underwent electrophoresis, and were transferred to nitrocellulose membrane as previously described. 3 After transfer, the membrane was incubated for 1 hour (Odyssey Blocking Buffer; LI-COR), followed by incubation for 1 hour with monoclonal mouse anti-H3 and polyclonal rabbit anti-acetyl-H3 at 0.5 g/mL in blocking buffer with 0.1% Tween-20. The membrane was washed four times for 5 minutes each in PBS with 0.1% Tween-20 (Fisher Scientific), followed by incubation for 1 hour with goat antimouse IgG (IRDye 800; LI-COR) and goat anti-rabbit IgG (IRDye 680; LI-COR) at 0.5 g/mL in blocking buffer with 0.1% Tween-20. The membrane was again washed four times for 5 minutes each in PBS with 0.1% Tween-20, imaged on an infrared scanner (LI-COR), and analyzed for band density (Odyssey software; LI-COR).
The expression of Brn-3a and Brn-3b was assayed at 48 hours after pharmacologic treatment as described here, with ECL detection as previously described. 3 Brn-3a, Brn-3b, and actin antibodies were used at 1 g/mL, 0.1 g/mL, and 0.2 g/mL respectively, with secondary antibodies used at 1:10,000 dilution.
Statistical Analysis
Comparisons among conditions for longest neurite and number of neurites per differentiated cell were performed using two-sided unpaired t-tests. Two-sample F-tests were used to establish whether equal or unequal variance was present. Comparisons between conditions for proportions of differentiated or PI-positive cells were performed with two-sample proportion tests. P Ͻ 0.05 was considered significant for all test statistics. Values stated in text are expressed as mean Ϯ SEM, and error bars in figures are Ϯ SEM.
RESULTS
HDAC Inhibition Causes RGC-5 Cell Differentiation, Which Differs Morphologically and Quantitatively from Differentiation Induced by Staurosporine
Both TSA (500 nM) and staurosporine (316 nM) induced the differentiation of RGC-5 cells, as defined by the presence three or more neurites longer than the soma (Fig.1) . Differentiation was not observed at any time point from untreated control and 300 L/well media compared with the standard 100 L/ well, but this effect was not observed with staurosporine (Fig.  3A) . Except for a large increase in the proportion of PI-positive cells with TSA differentiation at 50 L/well, no significant effects were observed in the proportion of PI-positive cells with TSA or staurosporine differentiation when the plating density or media volume was varied (Figs. 3A, 3B). These data collectively suggest that the observed increase in TSA differentiation sensitivity to plating density is caused by a conditioned media effect and not by direct cell-cell contact. The proportion of TSA-differentiated cells was similar between homologous conditions (i.e., 50 L/well media over 80 cells/mm 2 approximates the media/cell ratio of 100 L/well media over 160 cells/mm 2 ), indicating that cell-cell contacts are not necessary to explain the observed plating density sensitivity. However, the increase in the proportion of PI-positive cells at 50 L/well media over 80 cells/mm 2 compared with 100 L/well media over 160 cells/mm 2 (0.72 Ϯ 0.03 vs. 0.13 Ϯ 0.02; P Ͻ 0.0001) suggests that cell-cell contacts may be important not for differentiation but for survival after differentiation.
RGC-5 cells had a bimodal response to differentiation with TSA, unlike the graded response observed with staurosporine. of cells with two neurites was significantly lower than the proportion of cells with one neurite or three neurites. Furthermore, the response was stable because the frequency distribution was not observed to shift to the right (to greater neurite numbers per cell) at 120 hours after treatment. This observation of two distinct populations also validated the criterion of classifying cells as differentiated if three or more neurites longer than the soma were present. In contrast to the bimodal response to TSA, the differen- tiation induced by staurosporine was graded, with the distribution of undifferentiated cells at 0 hours progressively shifting to the right between 24 and 120 hours after treatment.
Dose-Response of RGC-5 Cells to HDAC Inhibition
The concentration dependence of differentiation with TSA was parabolic, whereas the effect on the proportion of PI-positive cells was exponential (Fig. 5) 
HDAC Inhibition-Differentiated RGC-5 Cells Are Mitotically Inactive
An important criterion for classifying a cell as differentiated is that it must become postmitotic on differentiation. To investigate whether RGC-5 cells differentiated with TSA became irreversibly postmitotic, cells were incubated with BrdU, followed by immunohistochemical staining for incorporation into chro- (Fig. 6 ).
Withdrawal of TSA or staurosporine from the culture at 24 hours had differential effects on mitotic activity measured at 72 hours (Fig. 6B) . TSA-differentiated cells became mitotically active and undifferentiated, and the continued presence of RGC survival factors did not prevent the resumption of proliferation (31%-33% [Ϯ5%] BrdU positive in all cases) or dedifferentiation. This effect was not observed with staurosporineinduced differentiation, whereby cells remained postmitotic. However, when TSA was withdrawn at 72 hours and mitotic activity was assayed at 120 hours (Fig. 6C) , cells remained mitotically inactive, the proportion of cells differentiated was the same as cultures in which TSA was not withdrawn, and the proportion of PI-positive cells was significantly decreased (0.41 Ϯ 0.04 [TSA withdrawn] vs. 0.75 Ϯ 0.04 [TSA maintained]; P Ͻ 0.0001). These results indicate that for RGC-5 cells, differentiation with TSA becomes irreversible somewhere between 24 and 72 hours. However, as early as 72 hours, the continuous presence of TSA caused elevated cell death without increasing the proportion differentiated. In contrast, the removal of staurosporine at 24 and 72 hours caused a significantly higher proportion of PI-positive cells at 72 and 120 hours, respectively, compared with cells maintained with staurosporine. Together, these observations suggest that the withdrawal of TSA did not cause dedifferentiation after 72 hours, whereas the withdrawal of staurosporine caused rapid dedifferentiation and death.
Effects of Neurotrophic Factors on Differentiation Mediated by HDAC Inhibition
A combination of neurotrophic factors known to increase RGC survival 10 was tested to determine whether this would be additive with differentiation mediated by HDAC inhibition. RGC-5 cells were treated with BDNF (50 ng/mL), CNTF (10 Fig. 8E ).
The effects of neurotrophic factors on differentiation mediated by staurosporine were different from those mediated by HDAC inhibition. RGC survival factors plus staurosporine significantly increased the number of neurites per differentiated cell compared with staurosporine alone (7.00 Ϯ 0.26 neurites vs. 5.89 Ϯ 0.33 neurites; P ϭ 0.012) at 72 and 120 hours (Fig. 7D) In contrast to what was seen with HDAC inhibition, no individual survival factor enhanced differentiation mediated by staurosporine, as observed at 72 hours (Fig. 8D) . 
HDAC Inhibition-Mediated Differentiation Induces Neuritogenesis
To assess the effect of TSA on neuritogenesis, RGC-5 cells were immunohistochemically stained for MAP2 and tau 24 hours after treatment with TSA (500 nM) and/or RGC survival factors (Fig. 9) . Although TSA-differentiated cell somas were stained by tau, cells with tau-positive neurites had stained preferentially in a single neurite, and staining was localized to the most distal aspects of the neurite, primarily in the growth cone. In contrast, MAP2 stained somas and neurites diffusely. A similar pattern has been reported in cultured rat hippocampal neurons. 11 In contrast, cells treated with only RGC survival factors did not exhibit this staining pattern (Fig. 9) , with tau and MAP2 colocalized everywhere. These results suggest that the single neurites with localized tau staining in TSA-differentiated cells are likely axons.
HDAC Inhibition-Mediated Differentiation Is Transcription Dependent
To investigate the mechanism of action for TSA, cells were treated with ␣-amanitin, a potent RNA-polymerase II inhibitor, 12 at 10 g/mL 4 hours before the addition of TSA (500 nM) or staurosporine (316 nM). Because staurosporine induces noticeable neurite outgrowth in minutes, cells were preincubated for 4 hours with ␣-amanitin to exclude the possibility that staurosporine would affect cell morphology before transcription was inhibited. Twenty-four hours after TSA and staurosporine were added, ␣-amanitin completely blocked neurite outgrowth in TSA-cotreated cells (Figs. 10A, 10B ). Longest neurite length, primary neurite count, and proportion differentiated were not different from those values in untreated control cells. Compared with TSA alone, ␣-amanitin-cotreated cells had significantly shorter longest neurites (47 Ϯ 4 m vs. 79 Ϯ 4 m; P Ͻ 0.0001), fewer primary neurites (1.67 Ϯ 0.11 neurites vs. 3.33 Ϯ 0.13 neurites; P Ͻ 0.0001), and no differentiation (Figs. 10D-F) . The proportion of PI-positive cells was significantly elevated compared with that found with TSA alone (0.33 Ϯ 0.05 vs. 0.08 Ϯ 0.02; P Ͻ 0.0001) but was statistically not different from that found with ␣-amanitin control cells (Fig. 10F) . In contrast to the observed total block of neuritogenesis with TSA, ␣-amanitin did not block staurosporine-mediated neurite outgrowth (Fig. 10C) . Longest neurite length was statistically not different from staurosporine alone, but primary
Tau
MAP2
Merge TSA + B/C/I/F Control + B/C/I/F FIGURE 9. HDAC inhibition differentiation induces true neurite outgrowth. RGC-5 cells were treated with 500 nM TSA and/or RGC survival factors and were immunohistochemically stained for tau (red) and MAP2 (green) 24 hours after treatment. Contrast was enhanced, and red and green images were merged to compare focal and diffuse staining. Moreover, the TSA photomicrographs were cropped to show enhanced detail. Although in TSA-differentiated cells MAP2 was observed diffusely throughout the soma and all neurites, tau was observed to be localized primarily to the soma and a single neurite (arrows). Furthermore, tau-positive neurites showed a distal gradient, with tau staining localized primarily to presumed growth cones. This pattern was not observed in cells treated solely with RGC survival factors because tau and MAP2 diffusely stained all projections from the soma. Scale bar, 50 m.
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neurite counts were significantly reduced (3.33 Ϯ 0.11 neurites vs. 4.39 Ϯ 0.18 neurites; P ϭ 0.00026), along with proportion differentiated (0.52 Ϯ 0.05 vs. 0.96 Ϯ 0.02; P Ͻ 0.0001; Figs. 10D-F) . The proportion of PI-positive cells was similar among control, TSA-, and staurosporine-treated cells coincubated with ␣-amanitin, suggesting that survival was not differentially affected. To test whether TSA simply induced process formation by nontranscriptionally inhibiting cytoplasmic HDAC-6, which acetylates and stabilizes microtubules, cells were treated with sodium butyrate, an HDAC inhibitor that does not inhibit cytoplasmic HDAC-6. 13 Twenty-four hours after treatment, differentiation with 50 mM Na butyrate in the presence or absence of RGC survival factors was similar to that induced by TSA (500 nM; Fig. 11 ). These results together make it likely that HDAC inhibition-mediated differentiation is transcriptional and that the observed processes are true neurites. 
Na Butyrate
Na Butyrate + B/C/I/F FIGURE 11. HDAC inhibition induces neuritogenesis independently of cytoplasmic HDAC-6. RGC-5 cells were treated with 50 mM Na butyrate with and without RGC survival factors. Na butyrate is an HDAC inhibitor that does not inhibit cytoplasmic HDAC-6. 13 Photomicrographs were taken at 200ϫ magnification 24 hours after treatment. Neuritogenesis was seen, suggesting that HDAC inhibition differentiates RGC-5 cells by acting on nuclear HDACs. Scale bar, 50 m. To further confirm that HDAC inhibition-mediated differentiation of RGC-5 cells is transcriptional, cell lysates were immunoblotted for the Brn-3a and Brn-3b transcription factors 48 hours after pharmacologic treatment. Cells treated with TSA and RGC survival factors were observed to have 1.4-and 2.0-fold increases in Brn-3a and Brn-3b (densitometry normalized to actin), respectively, compared with cells treated with RGC survival factors alone (Fig. 12) . Interestingly, Brn-3b expression in cells treated with staurosporine and RGC survival factors was downregulated compared with control cells, with 0.6-fold normalized density (Fig. 12) .
HDAC Inhibition and Staurosporine Are Synergistic with Respect to Neurite Outgrowth
Staurosporine alone does not induce differentiation or neurite outgrowth below a threshold of approximately 100 nM. 3 We treated RGC-5 cells with TSA (500 nM) and a subthreshold dosage of staurosporine (1 nM; Fig. 12D ) and found significantly longer longest neurites (121 Ϯ 10 m [120 hours] vs. 64 Ϯ 5 m [120 hours]; P Ͻ 0.0001) at 24 and 120 hours and increased primary neurite counts (4.56 Ϯ 0.12 neurites vs. 3.24 Ϯ 0.12 neurites; P Ͻ 0.0001) at 120 hours compared with TSA alone (Figs. 13A, 13B ). No statistical difference was observed in proportion differentiated or PI positive between cells treated with TSA alone and with 1 nM staurosporine (Fig. 13C) .
Staurosporine Does Not Inhibit HDAC
Although differentiation with HDAC inhibition was quantitatively and qualitatively different from that seen with staurosporine, it was possible that the effect of staurosporine could partly be attributed to HDAC inhibition. To test this possibility, lysates from cells treated with TSA (500 nM), staurosporine (316 nM), or controls were immunoblotted for total and acetylated class I histone H3. As expected, staurosporine showed no increase in H3 acetylation compared with control cells, whereas TSA-treated cells were approximately 2.7-fold increased in H3 acetylation (Fig. 14) . Similar results were obtained across all nuclear histones with cell-free assay in a fluorescent assay system (Fluor de Lys; Biomol, Plymouth Meeting, PA) 14 on HeLa nuclear extracts (data not shown). Brn-3a Brn-3b FIGURE 12. HDAC inhibition upregulates Brn-3a and Brn-3b expression. RGC-5 cells were treated with 500 nM TSA, 316 nM SS, or medium alone (Ctrl) in the presence of RGC survival factors. Cell lysates were immunoblotted for Brn-3a and Brn-3b 48 hours after treatment. Band density was normalized to actin. TSA treatment resulted in Brn-3a and Brn-3b levels 1.4-and 2.0-fold those of control cells, respectively, whereas staurosporine treatment resulted in the downregulation of Brn-3b to 0.6-fold that of control cells.
FIGURE 13
. HDAC inhibition and SS are synergistic with regard to the induction of neurite outgrowth. RGC-5 cells were treated with 500 nM TSA with (D) and without a subthreshold dose of SS at 1 nM. Photomicrographs were taken 24 and 120 hours after initial treatment to quantify longest neurite length (microns; A), number of neurites longer than the soma (B), and proportion of differentiated cells (C). The number of neurites in the TSA plus subthreshold SS condition was significantly larger than TSA alone 120 hours after treatment (B). Longest neurite length was also significantly augmented by subthreshold SS inclusion at 24 and 120 hours (A). However, the proportion differentiated was not significantly different from that of TSA alone at either time point (C). *Statistically significant (P Ͻ 0.05) difference between treatments. Scale bar, 50 m.
DISCUSSION
HDAC inhibition-mediated differentiation of RGC-5 cells was synergistic with neurotrophic factors that increase RGC survival. This combination resulted in increased viability, differentiated proportion, longest neurite length, and number of neurites extending from the soma. Only 50% of differentiated and neurotrophin-treated RGC-5 cells were viable on day 3, similar to what was seen in primary P1 RGCs treated with neurotrophic factors but less than the 90% survival rate of neurotrophic factor-treated P8 RGCs. 10 The likely reason for this difference is that rat RGCs undergo target deprivation-induced cell death during P1 to P4 15 and RGC-5 cells are immortalized at P1, at the major peak of developmental cell death. Surprisingly, RGC neurotrophic factors also had noticeable effects on HDACinhibitor-treated cell neurite outgrowth as early as 24 hours (before significant cell death occurred). This finding strongly suggests that adding RGC survival factors to HDAC inhibition had an effect beyond simply increasing cell viability; it also had an effect on morphology, even though the survival factors themselves showed no differentiating activity when used alone. Unlike what was seen with staurosporine-differentiated RGC-5 cells, the length of the longest neurite and the primary neurite count did not change over time with HDAC inhibition, in the presence or absence of RGC survival factors. This lack of effect on neurite extension was similar to what others have observed for primary cultures of RGCs, where neurotrophic factors alone do not induce significant axon elongation in the absence of suitable chemoattractive cues, such as growth on laminin or localized gradients of attractive/repulsive neurotrophic factors. 16, 17 Similarly, the fact that the number of differentiated cells had a bimodal distribution after HDAC inhibition but a graded distribution with staurosporine supports the notion that HDAC inhibition results in differentiation similar to the in vivo differentiation process. Cellular differentiation is similar to a switch, with cells passing rapidly from undifferentiated to differentiated states in a transcriptionally regulated process. 18, 19 The finding of a bimodal distribution of cells, clustered in undifferentiated and differentiated states, is consistent with turning of an all-or-nothing differentiation switch, a pattern seen only with transcription-dependent HDAC inhibition.
More support for HDAC inhibition-differentiated RGC-5 cells behaving similarly to RGCs is the effect of conditioned media. RGCs in vitro exhibit conditioned media effects, whereby survival is significantly enhanced by plating at higher rather than lower densities. 10 Our results with HDAC inhibition (but not differentiated mediated by staurosporine) were similar in that differentiation was enhanced by increasing densities at all levels except the highest.
The observation that tau localizes predominantly to the distal portions of single neurites in RGC-5 cells differentiated by HDAC inhibition suggests that true neuritogenesis occurred, not process formation caused by actin stress fibers, as has been reported in v-ras-transformed NIH 3T3 cells treated with TSA. 20 Although tau staining of distal aspects of neurites is actin dependent, the localization of tau specifically to one neurite is actin independent.
11 In other words, actin stress fiber formation cannot explain the enrichment of tau observed localized to one particular neurite, which is indicative of axons. Furthermore, the observed diffuse staining of MAP2 in all other neurites is consistent with these neurites being dendrites.
A likely mechanism for RGC-5 differentiation with HDAC inhibition is removal of the neuron gene-specific transcription repressor neuron-restrictive silencing factor (NRSF) from neuron-restrictive silencing element (NRSE). This process is a necessary, though not necessarily sufficient, component of in vivo central nervous system neuronal differentiation. 7 NRSEs are located in the promoter regions of many neuron-specific genes. NRSF, when bound to NRSE, sterically prevents transcription of these genes. TSA, however, inhibits the complexing of NRSE with NRSF. 21 NRSF recruitment to NRSE is mediated by the HDAC 1-and 2-containing transcription corepressor Sin3/ HDAC1,2.
22,23 When HDAC activity is inhibited, NRSE is released from NRSF, permitting transcription factor access to genes downstream of NRSE-containing promoters. This mechanism would also explain why, in our preliminary screening of HDAC inhibitors, the class 3 HDAC inhibitor nicotinamide 24 did not induce differentiation in RGC-5 cells. Sin3/HDAC1,2 is composed of only TSA-sensitive class 1 and class 2 HDACs. Our observations that Brn-3a and Brn-3b, transcription factors necessary for RGC differentiation, 25 were upregulated on TSA treatment fits this model because both are regulated by Math5 and NRSF and are upregulated during in vivo RGC differentiation. 26 Although staurosporine-differentiation is not dependent on transcription, in contrast to HDAC inhibition-mediated differentiation, a subthreshold concentration of staurosporine (1 nM) caused longer longest neurites and increased the number of neurites in the presence of HDAC inhibition. These data imply that though these two mechanisms differ, some common downstream transduction processes likely take place.
In summary, we found that HDAC inhibition of a committed retinal neuronal cell line, RGC-5, results in differentiation similar to that occurring during development and different from that observed with staurosporine-mediated differentiation. HDAC inhibition could potentially be used to differentiate RGC progenitors for use in repopulating the retina in optic neuropathies, resulting in RGCs that are more physiologically neurotrophic factor dependent. 
